Menopause is associated with weight gain, but the reasons why are not clear. In this study, the investigators will determine if reducing estrogen levels causes a decrease in the ability of the body to produce heat. If so, this would suggest this is one way that menopause may cause weight gain.
The purpose of this pilot study is to investigate the role of the female sex hormone estrogen, on metabolism, thermoregulation and energy expenditure. Weight and fat gain increase after the menopause, but reasons for this are not clear. Loss of estrogen may cause changes in how women regulate metabolism and thermoregulation, possibly leading to weight gain. Specifically, this study will determine how loss of estrogen affects facultative thermogenesis. Loosely defined, facultative thermogenesis represents heat production that is turned on when needed. For example, when body core temperature falls below a certain threshold, a shivering response is invoked in skeletal muscle to increase heat production and, thus, energy expenditure. However, exposure over several hours to mild cold temperatures that do not trigger shivering (16-20⁰ C) also induces an increase in energy expenditure (cold-induced non-shivering thermogenesis). Although several different tissues may contribute to this response, the recent identification of functional brown adipose tissue (BAT) in humans has promoted an interest in how BAT is activated in humans and its potential role in regulating energy balance and body weight. The investigators will measure BAT activity using PET/CT scans pre and post three months of estrogen suppression.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
6
Estrogen production will be suppressed for 3 months by administering a drug, lupron, that suppresses ovarian function
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Brown Adipose Tissue Activity
Brown adipose tissue activity will be measured using Positron Emission Tomography/computer tomography (PET/CT) before and after 3 months of estrogen suppression. Activity is quantified as the standard uptake value (SUV), It is a mathematically derived ratio that is a semiquantitative measure of the tracer uptake in a region of interest that normalizes the lesion activity to the injected activity and a measure of the volume of distribution (usually total body weight or lean body mass).
Time frame: Baseline and after 3 months of suppression
Cold Induced Thermogenesis
The increase in energy expenditure above resting during cold exposure
Time frame: Baseline and after 3 months of suppression
Fat Mass
Amount of body fat (in kg)
Time frame: Baseline and after 3 months of suppression
Fat Free Mass
Fat free mass measured by DXA
Time frame: Baseline and after 3 mo of suppression
Resting Energy Expenditure
Energy expenditure measured in the resting state
Time frame: after 3 months of suppression
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.